Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

boehringer ingelheim international gmbh - ipratropijev bromid; fenoterolijev bromid - inhalacijska raztopina za nebulator - ipratropijev bromid 0,25 mg / 1 ml  fenoterolijev bromid0,5 mg / 1 ml; fenoterolijev bromid 0,5 mg / 1 ml - fenoterol in ipratropijev bromid

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

sanofi-aventis d.o.o. - bromheksin - peroralna raztopina/inhalacijska raztopina za nebulator - bromheksin 1,83 mg / 1 ml - bromheksin

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

sanofi-aventis d.o.o. - bisakodil - svečka - bisakodil 10 mg / 1 svečka - bisakodil

Evropska unija - slovenščina - EMA (European Medicines Agency)

servier (ireland) industries ltd - agomelatine - depresivna motnja, major - psychoanaleptics, - zdravljenje velikih depresivnih epizod pri odraslih.

Evropska unija - slovenščina - EMA (European Medicines Agency)

curium pet france - piflufolastat (18f) - prostatične neoplazme - diagnostični radiofarmacevtiki - to zdravilo je samo za diagnostično uporabo. pylclari is indicated for the detection of prostate-specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high-risk pca prior to initial curative therapy,to localize recurrence of pca in patients with a suspected recurrence based on increasing serum prostate-specific antigen (psa) levels after primary treatment with curative intent. pylclari is indicated for use with positron emission tomography (pet).